Last reviewed · How we verify

NCT06634953

The Impact of Volleyball on Menstrual Symptoms

Completed Last updated 10 October 2024
What this trial tests

trial in Adolescent in 154 participants. Completed in 15 March 2024.

Timeline
3 January 2024
Primary endpoint
15 March 2024
15 March 2024

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
StatusCompleted
Study typeOBSERVATIONAL
Enrollment154
Start date3 January 2024
Primary completion15 March 2024
Estimated completion15 March 2024
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

Adults 10 to 19, female only, with Adolescent or Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to examine menstrual characteristics and symptoms in adolescent volleyball athletes compared to non-athlete adolescents. The main question it aims to answer is: How do menstrual symptoms and characteristics differ between adolescent volleyball athletes and non-athletes? The study included 154 adolescents aged 10-19, divided into 77 volleyball athletes (average age 15.09) and 77 non-athletes (average age 14.79). Assessments covered menstruation age, regularity, dysmenorrhea characteristics, and menstrual symptoms using the Menstrual Symptom Questionnaire (MSQ).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Adolescent

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06634953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing